The Benefits of a Mediterranean-style Diet
News Nov 21, 2016
Clarifying the mechanism of this harmful pathway is important because nearly 5 million people in the United States suffer heart failure as an age-related disease following heart attacks. Half of them die within five years, and the annual cost for health care, medications and missed work is $32 billion.
Knowledge of the dysfunctional lipid signaling that triggers heart inflammation and heart failure could be essential to discovering therapeutic treatments for the millions of aging patients at risk of heart failure after heart attacks.
The problem of heart failure is a nonresolving, overactive inflammation at the heart. After a tissue injury, such as death of muscle tissue in a heart attack, the body has a beneficial, early acute inflammation response that removes dead cells and begins repairs to the injured area. In healthy healing, the acute inflammation resolves, and a healing process follows.
In healthy healing, particular lipids that the body produces from essential dietary fat appear to act as signals to resolve the early acute inflammation, including a group of lipids called resolvins.
In contrast to such healthy healing, UAB researchers have found that a combination of age and excess omega-6 fatty acid in the mouse diet led to increased heart inflammation as compared to aged mice that ate a lower-fat, lab chow diet.
Intriguingly, the typical Western diet is much higher in the ratio of omega-6 fatty acids to omega-3 fatty acids, similar to the excess omega-6 fatty acid diet given to the mice. The so-called Mediterranean-style diet, which has much less meat, has a much lower ratio of omega-6 to omega-3 fatty acids, and people who eat a Mediterranean-style diet are known to develop less heart disease.
UAB researchers, led by Ganesh Halade, Ph.D., assistant professor in the Division of Cardiovascular Medicine, UAB Department of Medicine, report that four steps led to the nonresolving inflammation.
The aged mice that were fed with excess omega-6 fatty acid, in contrast to lean aged mice, had: 1) lower amounts of three types of lipoxygenase enzymes in the dead area of the heart muscle, enzymes that can produce resolving signal lipids such as the resolvins from dietary omega-3 fatty acids; 2) lesser amounts of resolvins and several other lipid signals that help resolve acute inflammation; 3) increased amounts of macrophage immune cells that are pro-inflammatory; and 4) increased kidney injury and increased levels of two signaling cytokines that promote inflammation — tumor necrosis factor-alpha and interleukin-1-beta.
Thus, as Halade and colleagues report in the journal Aging, excess fatty acid intake magnifies chemokine signaling after a heart attack in aged mice, and this drives the signaling network between the heart and spleen and the heart and kidneys toward a nonresolving microenvironment.
The excess omega-6 fatty acid for the mice came from enriching their diet with safflower oil. Techniques used to elucidate the dysregulated lipid signaling pathway in the aged mice included liquid chromatography-mass spectrometry metabolipidomics to analyze lipid mediators and flow cytometry to analyze immune cells.
Besides Halade, co-authors of the paper, “Aging Dysregulates D- and E-Series Resolvins to Modulate Cardiosplenic and Cardiorenal Network Following Myocardial Infarction,” are Vasundhara Kain, Ph.D., Laurence M. Black, Sumanth D. Prabhu, M.D., and Kevin A. Ingle, all of the Division of Cardiovascular Disease, UAB Department of Medicine.
At UAB, Prabhu is the Mary Gertrude Waters Chair of Cardiovascular Medicine.
Ocean Floor Mud Reveals Secrets of Past European ClimateNews
Samples of sediment taken from the ocean floor of the North Atlantic Ocean have given researchers an unprecedented insight into the reasons why Europe’s climate has changed over the past 3000 years.READ MORE
World’s Smallest Tape Recorder Is Built From MicrobesNews
Through a few clever molecular hacks, researchers at have converted a natural bacterial immune system into a microscopic data recorder, laying the groundwork for a new class of technologies that use bacterial cells for everything from disease diagnosis to environmental monitoring.
Existing 20-year-old Multiple Sclerosis Drug Effective Against Multi-resistant BacteriaNews
A widely-used and twenty-year-old medicine used to treat multiple sclerosis can also beat a type of multi-resistant bacteria for which there are currently only a few effective drugs.READ MORE